Since the initial description of the granular cell tumor in 1926, numerous other neoplasms, both benign and malignant, have been described to exhibit granular cell change. In most cases, diagnosis remains straightforward via recognition of retained histopathological morphology of the archetypal tumor, despite the presence of focal granular appearance. However, tumors with granular cell differentiation can present a diagnostic challenge either by mimicking alternative diagnoses, or by failing to exhibit architectural clues of the primary entity, thus requiring an immunohistochemical work-up. In light of this, it is important to be aware of the various entities that have been reported to exhibit granular cell morphology. In this review such tumors are discussed along with pertinent clinical and histopathological features.
INTRODUCTION
Granular cell differentiation is hallmarked by the presence of abundant eosinophilic granularity of cytoplasm. It is due to an increased number of secondary lysosomes, as evidenced by immunoreactivity to CD68, which is a macrophage marker related to lysosomal glycoproteins.
1 Granular cell change can occur focally or extensively in a wide variety of both benign and malignant tumors, and it is currently thought to represent a degenerative process leading to accumulation of lysosomes. 2 The conventional granular cell tumor (GCT) is the prototypical entity that invariably demonstrates granular differentiation, however, numerous other tumors with granular cell variants are potential mimickers. GCT, as evidenced by their immunohistochemical properties, are thought to be of neuroectodermal derivation, but many of the other entities that have granular cell variants are of non-neural lineage, ranging from mesenchymal to epithelial. Furthermore, they have been described in inflammatory conditions such as lobomycosis. 3 Thus, the presence of granularity does not portend a particular cell lineage. 4 Therefore, when granular cell change is encountered, immunohistochemistry may be necessary in attaining an accurate diagnosis. The purpose of this review is to discuss the various neoplasms and other conditions with documented granular cell features, and highlight the work-up and implications of such lesions. Basal cell carcinomas (BCC), fibrous papules, melanomas, leiomyomas, leiomyosarcomas, dermatofibrosarcomas, angiosarcomas, dermatofibromas (DF), ameloblastomas and primitive polypoid GCT are just some of the entities reported to have granular cell variants, which can be differentiated from GCT with immunohistochemical studies. These, among other entities that exhibit granular cell variants, are discussed below (Table 1) .
TUMORS THAT CAN EXHIBIT GRANULAR CELL CHANGE Granular cell tumors
Granular cell tumors, also known as Abrikossoff's tumor, granular cell myoblastoma, granular cell nerve sheath tumor and granular cell schwannoma, are rare, often benign-behaving neoplasms that were first described in 1926 by Abrikossoff. 5 They often present as a slowly growing painless nodule, and can arise in essentially any anatomical location, but occur most commonly in the head and neck. The tongue is the most common overall location. 6 These tumors unfailingly demonstrate extensive granular cell histology (Fig. 1) , and characteristically have large, round eosinophilic granules surrounded by a clear halo ( Fig. 2 ) called pustulo-ovoid bodies of Milian (POB). One recent series noted that 47 of 47 GCT contained POB, suggesting that their presence is an important clue to the diagnosis. 7 Histologically, GCT have poorly circumscribed borders and can induce pseudoepitheliomatous hyperplasia of the overlying epidermis (Fig. 3) , which can be mistaken for squamous cell carcinoma. 6 Cytology usually shows ovoid or polygonal cells with abundant eosinophilic, coarsely granular cytoplasm with a lack of pleomorphism or mitoses. The nuclei are typically uniform, hyperchromatic and eccentrically located. 6 Treatment of choice for benign disease is local, wide excision. 5 Rare atypical and malignant forms of GCT have also been reported with metastases usually occurring when the tumor arises from a visceral or deep site.
Some cases may show epidermotropism (Fig. 4) and may be confused with melanoma in situ. 8 The cytoplasmic granules of GCT are periodic acid-Schiff (PAS) positive and diastase resistant. The immunohistochemical profile of GCT is characterized by positive staining for S100 protein (Fig. 5) , neuronspecific enolase (NSE) and vimentin. Tumor cells do not stain with epithelial, melanocytic, muscle, endothelial or glial cell markers. This staining pattern is suggestive of Schwann cell origin. 5 
Atypical fibroxanthoma
Since its discovery in 1961, several histological variants of atypical fibroxanthomas (AFX) have been described, including a rare, granular cell variant. 9,10 AFX typically present as a rapidly growing nodule on the head and neck, usually in males with sun-damaged skin. The typical histological description of an AFX includes pleomorphic spindled and epithelioid cells containing foamy cytoplasm, hyperchromatic nuclei and atypical mitoses. AFX, a diagnosis of exclusion, can be difficult to distinguish from other malignant neoplasms such as squamous cell carcinoma and melanoma. The granular cell variant of AFX is exceedingly rare (Figs 6,7) In one study, granular cell changes were appreciated in three (1.8%) of 171 cases of AFX. Granular cell AFX stains negatively for S100 protein, making it easily distinguishable from conventional or malignant CGT. Workup and diagnosis of granular AFX is the same as the prototypical variant, and there does not appear to be any prognostic implications. Staining is positive for CD68 and vimentin, and negative for Melan-A, human melanoma black (HMB)-45, S100 protein, pan-cytokeratin (CK) and actin. 11, 12 Malignant fibrous histiocytoma, a malignant counterpart to AFX, has also been reported to mimic GCT by displaying a granular morphology. 13 
Angiosarcoma
Angiosarcoma is a relatively rare sarcoma of endothelial lineage, with most cases of cutaneous angiosarcoma arising on the head and neck of elderly patients.
14 Risk factors include radiation exposure, morbid obesity and chronic lymphedema, especially postmastectomy. Angiosarcoma has a somewhat protean histopathology, with the most well-known variant being the epithelioid type, which can mimic other malignant neoplasms. Granular cell change in angiosarcoma is extremely rare (Fig. 8 ).
Typical areas of angiosarcoma can be seen, and these stain positively for CD31/34 and negatively for S100 protein. Granular 14 
Dermatofibroma
Dermatofibromas, also known as fibrous histiocytomas, represent one of the most common benign cutaneous soft tissue tumors. They most often occur on the extremities of middleaged adults, and often a history of trauma or insect bite is elicited. They typically present as a small, red-brown nodule that exhibits dimpling upon pinching. It is unclear whether DF represent a reactive or neoplastic process.
Numerous variants of DF have been described, occasionally making diagnosis challenging. 15 In addition to common fibrous histiocytoma, other variants described to date include aneurysmal, hemosiderotic, cellular, epithelioid, atypical, lipidized, clear cell, palisading, atrophic, keloidal, granular cell, myxoid, lichenoid, balloon cell and signet-ring cell variants. More than one pattern can be seen in a single lesion, and some variants have clinical implications, such as the cellular type, which has a higher recurrence rate. 15 Granular cell change in DF, first reported in 1997, is only rarely reported. 16 The granular cells are reportedly S100 protein negative, and PAS positive (diastase resistant), while the conventional DF cells stain for vimentin and factor XIIIa. 15 Granular change has been reported in traumatized DF, further evidence that trauma leading to degenerative changes may be a catalyst to development of granular morphology. 17, 18 Granular DF is not known to have any clinical implications. 
Dermatofibrosarcoma protuberans
Dermatofibrosarcoma protuberans (DFSP) is a fairly uncommon, slow-growing tumor of the skin that typically manifests as a reddish, multinodular mass. It exhibits locally aggressive behavior and seldom metastasizes, but it can locally recur. 19 Genetically, DFSP is characterized by a reciprocal translocation t(17;22)(q22;q13) leading to a fusion of the COL1A1 gene and the PDGFB gene. The consequence of this is constitutive activation of the PDGFB receptor, a type III tyrosine kinase receptor. 19 Histologically, DFSP is a low-grade sarcoma that is characterized by poorly circumscribed tumor cells composed in fascicles arranged in a storiform (or cartwheel) pattern that invades the entire dermis with extension to the subcutis. 19 Cytology is quite benign with monomorphic spindle-shaped cells that show few mitotic figures. CD34 remains the primary immunohistochemical marker for diagnosis of DFSP. Several histological variants have been described including pigmented (Bednar tumor), myxoid, palisading, atrophic, DFSP with fibrosarcomatous areas, DFSP with areas of giant cell fibroblastoma, DFSP with foci of myofibroblastic differentiation, sclerosing/sclerotic DFSP and the granular cell variant. 19, 20 Three cases of the granular cell variant have been reported to date. 20 Granular cells are strongly positive for NK-inhibitory-factor (NK1C3), but negative for S100 protein. 20 The COL1A1-PDFGB gene fusion is reportedly positive in granular DFSP, and can aid in the diagnosis of unclear cases. 20 
Melanocytic nevi and melanoma
Though not often reported, melanocytic nevi can exhibit granular cell change. 21 The staining pattern is the same as that of normal melanocytic nevi with the exception of consistent positivity for HMB-45 in granular cells, while intradermal nevocytes are negative. 21 In contrast, S100 protein and Melan-A diffusely stain both typical and granular nevocytes. The HMB-45 and PAS positivity of the granular cells suggest that the granular melanocytes have accumulated increased, activated melanosomes or lysosomes. 21 Amelanotic melanoma has been reported with granular cell change. 22 GCT, especially if atypical or malignant, can share cytomorphological and architectural features with malignant melanoma, when the latter shows granular cell change. In many cases, these neoplasms can be differentiated from each other on histological grounds, but distinction may sometimes be challenging. 23 GCT and malignant melanoma can be reliably differentiated on the basis of immunohistochemical staining in the majority of cases. Although not always positive in malignant melanoma, HMB-45 expression is 100% specific for the diagnosis, with Melan-A being only slightly less specific, as rare cases of GCT have shown focal positivity. 23 
Fibrous papule
Fibrous papules (FP), a subtype of angiofibroma, are common, benign skin lesions that present as solitary skin-colored papules on the face of adults. Histologically, they show a proliferation of stellate fibroblasts along with blood vessels, a fibrotic stroma and occasionally scattered lymphocytes. 24 FP have several histological variants including hypercellular, clear cell, pigmented, pleomorphic, inflammatory and granular subtypes (Fig. 9) . Like the other tumors presented herein, granular change in FP is rare and has only been reported several times in the published work. Granular FP reportedly stain positively with PAS, CD68 and NKI/C3, and negatively for S100 protein. 25 
Basal cell carcinoma
Basal cell carcinoma, the most common malignant neoplasm of the skin, is noted for its numerous histological variants, likely a reflection of its origin which is that of pluripotent epithelial germ cells. 26 Previously described BCC variants include the following: solid; nodular; superficial multicentric; cystic; adenoid; adenocystic; morphea-like; fibroepithelioma; adamantinoid; metatypical (basosquamous, basaloid adnexal carcinoma); calcifying; ossifying; basal cell with follicular differentiation; basal cell with eccrine differentiation; basal cell with sebaceous differentiation (sebaceous epithelioma); and various combinations of these types. 26 With the exception of the morpheaform and metatypical types, the rest behave in a similar fashion. 26 In 1979, Barr and Graham documented the first two cases of BCC with prominent granular cell change. 26 Such tumors exhibit conventional features of typical BCC with basaloid cells, nodular growth pattern, peripheral palisading, associated tumor-stromal clefting and abundant extracellular mucin. 27 The granular change (Fig. 10 ) often composes the central portion of tumor nodules with typical palisaded basaloid cells making up the periphery. 28 As with the classical GCT, pustulo-ovoid bodies have been reported in granular BCC, suggesting lack of specificity of this finding. 26 Clear cell and granular change often coincide in BCC, and these changes may represent a spectrum of degenerative change. 29 The granular BCC in the published work are PAS negative or weakly positive. 29 Immunohistochemical examination demonstrates strong, diffuse positivity for AE1/AE3, CK5/6, CK8/18 and p63. 27 All cases of granular BCC have been found to be negative for S100 protein, carcinoembryonic antigen, NSE and melanocytic markers. 27 Clinically, this variant behaves similarly to conventional BCC, and is successfully treated with complete excision. 27 The diagnosis may be complicated by the absence of demonstrable connection of the tumor to the epidermis in the planes of section examined, or absence of more conventional features of BCC, making it important to be aware of this BCC variant. 27 As with BCC, trichoblastoma can exhibit granular change as well, and both are rare findings (3/1000 trichoblastomas; 1.3/ 10 000 BCC). 29 
Smooth muscle tumors
Smooth muscle tumors, such as leiomyoma and leiomyosarcoma, can demonstrate a number of distinctive histopathological alterations, including epithelioid, clear cell, granular cell and myxoid change. Tumors with mixtures of epithelioid, clear and granular cells have also been reported. Degenerative changes, such as edema, calcification, hyalinization, hemorrhage and cystic degeneration are frequently found in leiomyoma. 30 Granular cell change in leiomyomas is an infrequently reported alteration, and is thought to be degenerative in nature. These tumors are positive for actin, PAS, vimentin, desmin and smooth muscle myosin, but negative for S100 protein. 31 Differentiation of leiomyoma and its malignant counterpart is based primarily on pleomorphism and number of mitoses. fascicular, with cigar-shaped nuclei, and also show immunoreactivity for desmin and/or caldesmon and usually smooth muscle actin (SMA) as well.
Dermal non-neural GCT
Dermal non-neural GCT (NN-GCT), also known as primitive polypoid GCT, was first described by LeBoit in 1991 and has since been reported upwards of 30 times. 4, 32 The lesions tend to be painless, papulonodular or polypoid lesions, and may ulcerate. They are often small at presentation, but can grow to approximately 15 mm in dimension, typically located on the extremities, or the head and neck. 33 Non-neural GCT exhibit different histopathology compared with that of conventional GCT of Schwann cell origin. The latter is often small and poorly circumscribed and located in the deep dermis with cytology showing bland nuclei with few mitoses. Furthermore, conventional GCT can induce epidermal or pseudoepitheliomatous hyperplasia, and perineural invasion is not uncommon. Comparatively, NN-GCT have a polypoid architecture with an epidermal collarette, and are usually located in the papillary dermis with sharp peripheral circumscription. They also lack the epidermal hyperplasia often seen in conventional GCT. The cytology of NN-GCT is that of spindle-shaped, round or polygonal cells with abundant granular cytoplasm and, in contrast to conventional GCT, cytological atypia with increased mitotic activity is not an uncommon feature. 33 Immunohistochemically, a specific lineage of cellular differentiation is not apparent, and NN-GCT is considered a diagnosis of exclusion. 34 They are negative for S100 protein (easily distinguished from conventional GCT), SMA, desmin, CD34, cytokeratins and melanocytic markers (HMB-45 or Melan-A). Focal, weak CD68 staining has been reported, but is not conclusive of histiocytic origin. The only consistent diffuse cytoplasmic staining was for antibody NK1-C3, a very sensitive marker of granular cell change, irrespective of histogenesis. 33 Some of these lesions may have prominent desmoplastic stroma. 34 NN-GCT has a good prognosis and should be considered benign. Local recurrence is possible and therefore complete excision is advised. 33 The clinical evolution is typically indolent, with three cases reporting lymph node metastasis. [34] [35] [36] Hence, appropriate follow up should be instituted in all patients both for surveillance and to allow further characterization of the behavior of this uncommon neoplasm. 36 
Histiocytoses
Several benign histiocytotic lesions have been described to have a granular variant, and these include solitary reticulohistiocytoma (solitary epithelioid histiocytoma, SEH) and epithelioid cell histiocytoma (ECH), which is a variant of DF. Reticulohistiocytoma is a distinctive, uncommon lesion characterized by dermal infiltration of large-sized eosinophilic histiocytes with predominantly epithelioid morphology. It usually occurs as a solitary, asymptomatic, cutaneous papule or nodule on the head and neck or the upper trunk, most commonly affecting young or middle-aged individuals. 37 Rarely, SEH may occur as a systemic disease, so-called multicentric reticulohistiocytosis, involving skin and synovial membranes with concurrent destructive arthritis. This condition has also been reported in association with malignancy, suggesting that at least some cases may be paraneoplastic in nature. 37 Immunohistochemically, the epithelioid cells showed positivity to vimentin and CD68 along with no staining to S100 protein and CD1a, confirming their histiocytic nature. 37 NN-GCT described above is another distinctive entity that can potentially mimic SEH, its granular cells being negative to S100 protein and focally positive to CD68. However, it is characterized by significant cellular atypia, increased mitotic activity and an expansile growth pattern, all features lacking in SEH. 37 Epithelioid cell histiocytoma, considered a variant of DF/fibrous histiocytoma, is characterized by angulated, epithelioid cells with abundant eosinophilic cytoplasm, and a prominent vascular component. 38 These histological findings simulate those of Spitz's nevi and, to a lesser degree, pyogenic granuloma, reticulohistiocytoma, atypical fibrous histiocytoma, epithelioid hemangioma, neurothekeoma, cutaneous rhabdoid tumor, non-lipidized xanthogranuloma and epithelioid sarcoma. 38 ECH is S100 protein negative, and stains positively with factor XIIIa and CD68. 39 These tumors can also fit the profile of NN-GCT. 39 
Neurofibroma
Granular cell change has rarely been reported in neurofibroma.
It is believed to be due to degenerative changes. 40 Puri et al.
reported a 61-year-old man with a papule on his right clavicle. The biopsy showed lobules of vacuolated cells with clear and granular cytoplasm and scattered mast cells. The cells were strongly positive with S100 protein, and focally with CD68. MART-1 staining was negative. Based on these findings, the authors concluded that the lesion represented neurofibroma with granular cell change.
Ameloblastoma
Ameloblastoma is a benign odontogenic tumor that originates almost exclusively in the jaw, often in the posterior mandible, resulting in pain and swelling. It histologically demonstrates peripheral columnar cells with hyperchromatic, reversely polarized nuclei, arranged in a palisaded pattern. 41 This tumor also has a rare, granular cell subtype and, like the tumors described above, the granules represent the accumulation of lysosomes as a result of degenerative changes. 41 Likewise, the granular cell ameloblastoma reportedly behaves the same as the archetypal variant, which is locally aggressive with a high rate of recurrence. 41 Immunohistochemical analysis for granular ameloblastoma is reportedly positive for CK, CD68, lysozyme and a1-antichymotrypsin, but negative for vimentin, desmin, S100 protein and NSE and CD15, indicating epithelial origin and lysosomal aggregation. 41 Although classical GCT often arise in the mouth, they can be easily differentiated from granular ameloblastoma via clinical presentation and immunohistochemical studies.
INFLAMMATORY CONDITIONS WITH GRANULAR CELL CHANGE
Occasionally, inflammatory conditions can exhibit granular differentiation on histology. Therefore, the presence of granular cells does not necessarily imply the presence of neoplasia. One such example of this phenomenon has been reported in the fungal infection lobomycosis caused by Loboa loboi. 3 Lobo's disease is a rare, deep fungal infection that has been reported in tropical climates and has been associated with exposure to dolphins. 3 The histology of Lobo's disease is marked by numerous fungal organisms that appear as chains of yeast-like cells with thick walls amidst extensive granulomatous inflammation with histiocytes, giant cells and other inflammatory cells. 2 The organisms are 7-15 lm in diameter and can be seen easily with hematoxylin-eosin, but PAS and silver stains make them more conspicuous. 3 In the reported case with granular differentiation, the fungal cells were packed with electron-dense granules, and the histiocytes contained a granular material as well (Fig. 11) . Via electron microscope, the histiocytic cytoplasmic inclusions were found to be breakdown products of the fungal cell walls. These granular-appearing cells in the past had been considered granular myoblastoma cells.
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CONCLUSION
It is important for dermatologists and dermatopathologists to be aware of the varying entities that may exhibit granular cell changes as they range from benign to malignant. The differential diagnosis may initially be broad, but careful evaluation of clinical, histological and immunohistochemical findings should facilitate accurate diagnosis. 2, 9 A wide variety of entities with different lines of differentiation may present with a granular cell population, such as leiomyoma and leiomyosarcoma, rhabdomyomas, benign and malignant fibrous histiocytoma, ECH, DF, dermatomyofibroma, DFSP, fibroxanthoma, AFX, cutaneous angiosarcoma, FP, BCC, adnexal tumors, melanoma, benign melanocytic lesions and metastatic tumors, that is, renal cell carcinoma, melanoma or breast carcinoma. 42 When no specific line of differentiation can be proved in a GCT, a diagnosis of NN-GCT has to be considered. 34 The granular cell variants of these tumors usually contain portions that retain histological features characteristic of the exemplary neoplasm and have a similar immunophenotype. 43 In no reports was a granular differentiation associated with altered clinical course or prognosis. All granular variants are rare with BCC and NN-GCT representing most of the reported cases. Granular cell change is currently thought to represent a degenerative process leading to accumulation of lysosomes, and is likely to be continually reported in a wide variety of tumors.
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